Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Receivables - Net (2018 - 2025)

Historic Receivables - Net for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $4000.0.

  • Precision Biosciences' Receivables - Net fell 9787.23% to $4000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4000.0, marking a year-over-year decrease of 9787.23%. This contributed to the annual value of $229000.0 for FY2024, which is 7458.38% down from last year.
  • Latest data reveals that Precision Biosciences reported Receivables - Net of $4000.0 as of Q3 2025, which was down 9787.23% from $4000.0 recorded in Q1 2025.
  • Precision Biosciences' 5-year Receivables - Net high stood at $50.5 million for Q2 2022, and its period low was $4000.0 during Q1 2025.
  • Its 5-year average for Receivables - Net is $4.4 million, with a median of $488000.0 in 2021.
  • Its Receivables - Net has fluctuated over the past 5 years, first soared by 1024979.51% in 2022, then plummeted by 9897.44% in 2025.
  • Over the past 5 years, Precision Biosciences' Receivables - Net (Quarter) stood at $488000.0 in 2021, then surged by 47.54% to $720000.0 in 2022, then grew by 25.14% to $901000.0 in 2023, then crashed by 74.58% to $229000.0 in 2024, then crashed by 98.25% to $4000.0 in 2025.
  • Its Receivables - Net was $4000.0 in Q3 2025, compared to $4000.0 in Q1 2025 and $229000.0 in Q4 2024.